Multiple Sclerosis (MS)
Multiple Sclerosis (MS) is a chronic, inflammatory disease that affects the central nervous system. MS can cause a variety of symptoms, including changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, severe fatigue, cognitive impairment, problems with balance, over heating and pain. MS will cause impaired mobility and disability in more severe cases.
Multiple sclerosis affects neurons, the cells of the brain and spinal cord that carry information, create thought and perception, and allow the brain to control the body. Surrounding and protecting some of these neurons is a fatty layer known as the myelin sheath, which helps neurons carry electrical signals. MS causes gradual destruction of myelin and transection of neuron axons in patches throughout the brain and spinal cord. The name multiple sclerosis refers to the multiple scars on the myelin sheaths. This scarring causes symptoms which vary widely depending upon which signals are interrupted.
The predominant theory today is that MS results from attacks by an individual's immune system on the nervous system and it is therefore usually categorized as an autoimmune disease. There is a minority view that MS is not an autoimmune disease, but rather a metabolically dependent neurodegenerative disease.Although much is known about how MS causes damage, its exact cause remains unknown.
Multiple sclerosis may take several different forms, with new symptoms occurring either in discrete attacks or slowly accruing over time. Between attacks, symptoms may resolve completely, but permanent neurologic problems often persist; especially as the disease advances. MS currently does not have a cure, though several treatments are available which may slow the appearance of new symptoms.
MS primarily affects adults, with an age of onset typically between 20 and 40 years, and is more common in women than in men.
...More at Wikipedia
Related Links:
Multiple Sclerosis (MS)
Questions recently asked by other users
Latest Multiple Sclerosis News From Medical News Today.
- Opexa Therapeutics And Myelin Repair Foundation Partner On Novel Multiple Sclerosis Research Program
- Regulatory Immune Cells Not Defective In Multiple Sclerosis
- MS Market Is Estimated To Be Worth Almost US$8 Billion In 2008, With A Growth Rate Of 10.6% Year-On-Year
- Multiple Sclerosis - Jeffery D. Kocsis, Ph.D. And Wayne State Graduate To Receive The Da Vinci Lifetime Achievement Award
- New Quality Assurance On The Way For Health And Social Care Information, UK
- Enrollment Complete In 15-Year Long-Term Follow-Up Study Evaluating Impact Of AVONEX(R) In Patients With Relapsing Multiple Sclerosis
- Study Highlights Link Between Vitamin D And Multiple Sclerosis
- World-Class MS Information At The Touch Of A Button
- Nutra Pharma Announces Initial Positive Safety Data From Clinical Study In Adrenomyeloneuropathy (AMN)
- European Medicines Agency Update On Progressive Multifocalleukoencephalopathy (PML) And Tysabri
- BioMS Medical Announces Positive Interim Analysis On Phase III Trial Of Dirucotide (MBP8298) For Multiple Sclerosis
-
Farthar

-
Fancystuff

How does this condition aff... -
kmilne115

-
Rainmaker

-
queen_racewife

-
Vivschaff

My husband was diagnosed wi... -
cutee_n_camo

-
twwgigi@msn.com

